Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Rosuvastatin has Slight Edge Over Atorvastatin in reduction of all cause mortality among patients with dislipedemia, suggests study Dr Riya Dave9 Nov 2024 8:45 AM ISTResearchers have found that while rosuvastatin and atorvastatin are two of the most commonly prescribed drugs in managing cholesterol, rosuvastatin...
LENS trial a first of its kind large scale trial shows striking 27% reduction in diabetic retinopathy progression MD Brand Connect13 Aug 2024 11:51 AM ISTPresented at the ADA Diabetes Congress 2024, the LENS TRIAL was specifically designed to investigate the effect of Fenofibrate on eye outcomes in...
High Apolipoprotein B- Potential Risk Factor for CVD: Latest Indian Experience MD Brand Connect30 July 2024 12:27 PM ISTElevated levels of apolipoprotein B is a potential risk factor for cardiovascular disease (CVD) among Indians, a recent study has reported. The...
Modify phase IV CT Protocol: CDSCO panel Tells Akums Pharma on FDC Bempedoic acid, Rosuvastatin Calcium Dr. Divya Colin26 Nov 2023 5:45 PM ISTNew Delhi: After reviewing the Phase IV clinical trial protocol of the fixed-dose combination Bempedoic acid plus Rosuvastatin Calcium presented by...
Medical Bulletin 20/October/2023 Isra Zaman20 Oct 2023 3:00 PM ISTHere are the top medical news of the day:A surprising new reason of Long COVIDIn a recent discovery, researchers have unveiled a potential key to...
Commonly prescribed statin increases risk of type 2 diabetes, finds BMJ study Isra Zaman20 Oct 2023 9:15 AM ISTTwo widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary...
Rosuvastatin not superior to Atorvastatin among patients with coronary artery disease: LODESTAR TRIAL Niveditha Subramani5 Sept 2023 11:15 AM ISTCoronary artery disease is a global threat making cardiac deaths a major concern. The major blood vessels i.e coronary arteries are incapable of...
USV Launches Roseday CV at a Patient-Centric Price for Indian Cardiac Patients MD Brand Connect24 Aug 2023 12:04 PM ISTThe recent AHA/ACC 2023 Guidelines for Chronic Coronary Disease recommend considering medication costs to prevent cost-related non-adherence....
Aspirin combined with rosuvastatin best combo for CVD prevention Medha Baranwal24 March 2023 11:15 AM ISTChina: A recent study published in Scientific Reports has suggested that Rosuvastatin is the best statin to complement aspirin therapy for the most...
JB Pharma acquires leading brand of Rosuvastatin- Razel and combinations Dr. Nandita Mohan20 Dec 2022 1:05 PM ISTNew Delhi: Leading brand of Rosuvastatin, Razel will now be offered from JB Pharma as the company has now entered into an agreement with Glenmark...
JB Pharma forays into Statin segment, acquires Razel franchise from Glenmark for Rs 314 crore Ruchika Sharma15 Dec 2022 4:00 PM ISTNew Delhi: JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals...
